Literature DB >> 9579151

Randomised controlled trial of tyrosine supplementation on neuropsychological performance in phenylketonuria.

M L Smith1, W B Hanley, J T Clarke, P Klim, W Schoonheyt, V Austin, D C Lehotay.   

Abstract

OBJECTIVE: To test the efficacy of tyrosine supplementation, as an adjunct to dietary treatment, on neuropsychological test performance in individuals with phenylketonuria.
DESIGN: A randomised controlled trial of tyrosine supplementation using a double blind crossover procedure with three four week phases.
SETTING: The Hospital for Sick Children, Toronto. PARTICIPANTS: 21 individuals with phenylketonuria (ages 6 to 28 years, mean 11.3). INTERVENTION: Participants were given 100 mg/kg body weight/d of L-tyrosine or L-alanine (placebo).
RESULTS: At baseline, performance on several of the neuropsychological test measures was correlated with tyrosine levels. Dietary supplements of tyrosine increased plasma tyrosine concentrations; however, no change in test performance was found across the tyrosine and placebo phases of the study.
CONCLUSIONS: Tyrosine supplementation of this type does not appear to alter neuropsychological performance in individuals with phenylketonuria.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9579151      PMCID: PMC1717450          DOI: 10.1136/adc.78.2.116

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  38 in total

1.  Increased vigilance and dopamine synthesis by large doses of tyrosine or phenylalanine restriction in phenylketonuria.

Authors:  H C Lou; C Lykkelund; A M Gerdes; H Udesen; P Bruhn
Journal:  Acta Paediatr Scand       Date:  1987-07

2.  Where do the depleted plasma amino acids go in phenylketonuria?

Authors:  H N Christensen
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

3.  The assessment of attention: I. Standardization and reliability of a behavior-based measure.

Authors:  M Gordon; B B Mettelman
Journal:  J Clin Psychol       Date:  1988-09

4.  Biochemical and nutritional status of children with hyperphenylalaninaemia.

Authors:  A M Nord; L McCabe; E R McCabe
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  Behavior disturbance in 8-year-old children with early treated phenylketonuria. Report from the MRC/DHSS Phenylketonuria Register.

Authors:  I Smith; M G Beasley; O H Wolff; A E Ades
Journal:  J Pediatr       Date:  1988-03       Impact factor: 4.406

6.  Intelligence and behaviour in children with early treated phenylketonuria. A report from the MRC/DHSS phenylketonuria register.

Authors:  I Smith; M Beasley
Journal:  Eur J Clin Nutr       Date:  1989       Impact factor: 4.016

7.  Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age.

Authors:  R Koch; C Azen; E G Friedman; M L Williamson
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets.

Authors:  J T Clarke; R D Gates; S E Hogan; M Barrett; G W MacDonald
Journal:  Am J Ment Retard       Date:  1987-11

9.  Neuropsychological deficits in early treated phenylketonuric children.

Authors:  B F Pennington; W J van Doorninck; L L McCabe; E R McCabe
Journal:  Am J Ment Defic       Date:  1985-03

10.  Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment for phenylketonuria in adolescents.

Authors:  H C Lou; F Güttler; C Lykkelund; P Bruhn; A Niederwieser
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

View more
  14 in total

Review 1.  Phenylketonuria: tyrosine beyond the phenylalanine-restricted diet.

Authors:  F J van Spronsen; P G Smit; R Koch
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

2.  Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria.

Authors:  Thales Preissler; Ivi Juliana Bristot; Bruna May Lopes Costa; Elissa Kerli Fernandes; Elenara Rieger; Vanessa Trindade Bortoluzzi; Itiane Diehl de Franceschi; Carlos Severo Dutra-Filho; José Claudio Fonseca Moreira; Clovis Milton Duval Wannmacher
Journal:  Metab Brain Dis       Date:  2015-11-16       Impact factor: 3.584

Review 3.  Large neutral amino acids in the treatment of PKU: from theory to practice.

Authors:  Francjan J van Spronsen; Martijn J de Groot; Marieke Hoeksma; Dirk-Jan Reijngoud; Margreet van Rijn
Journal:  J Inherit Metab Dis       Date:  2010-10-26       Impact factor: 4.982

Review 4.  Dietary interventions for phenylketonuria.

Authors:  Vanessa J Poustie; Joanne Wildgoose
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

5.  Dietary interventions for phenylketonuria.

Authors:  Elisabeth Jameson; Tracey Remmington
Journal:  Cochrane Database Syst Rev       Date:  2020-07-16

Review 6.  Tyrosine supplementation for phenylketonuria.

Authors:  Diana Webster; Joanne Wildgoose
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 7.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

8.  In vivo catecholaminergic metabolism in the medial prefrontal cortex of ENU2 mice: an investigation of the cortical dopamine deficit in phenylketonuria.

Authors:  Tiziana Pascucci; Giacomo Giacovazzo; Diego Andolina; David Conversi; Fabio Cruciani; Simona Cabib; Stefano Puglisi-Allegra
Journal:  J Inherit Metab Dis       Date:  2012-03-24       Impact factor: 4.982

9.  Solvothermal Preparation of a Lanthanide Metal-Organic Framework for Highly Sensitive Discrimination of Nitrofurantoin and l-Tyrosine.

Authors:  Tian-Tian Wang; Jing-Yi Liu; Rui Guo; Jun-Dan An; Jian-Zhong Huo; Yuan-Yuan Liu; Wei Shi; Bin Ding
Journal:  Molecules       Date:  2021-06-16       Impact factor: 4.411

10.  International Society of Sports Nutrition position stand: energy drinks.

Authors:  Bill Campbell; Colin Wilborn; Lem Taylor; Mike Greenwood; Stephen Schmitz; Rick Collins; Jose Antonio; Paul La Bounty; Mike T Nelson; Tim N Ziegenfuss; Hector L Lopez; Jay R Hoffman; Jeffrey R Stout; Doug S Kalman; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2013-01-03       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.